AIA
RMD icon

Avalon Investment & Advisory’s ResMed RMD Stock Holding History

Avalon Investment & Advisory’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-24,918
Closed -$2.84M – 354
2018
Q4 		$2.84M Buy
24,918
+1,118
+5% +$120K 0.07% 182
2018
Q3 		$2.75M Buy
23,800
+1,663
+8% +$182K 0.08% 212
2018
Q2 		$2.29M Buy
22,137
+1,963
+10% +$199K 0.07% 211
2018
Q1 		$1.99M Buy
20,174
+1,939
+11% +$183K 0.06% 217
2017
Q4 		$1.54M Sell
18,235
-14,247
-44% -$1.18M 0.05% 222
2017
Q3 		$2.5M Sell
32,482
-243
-0.7% -$18.6K 0.08% 168
2017
Q2 		$2.55M Buy
32,725
+418
+1% +$29.9K 0.08% 167
2017
Q1 		$2.33M Buy
32,307
+3,143
+11% +$217K 0.08% 168
2016
Q4 		$1.81M Buy
29,164
+109
+0.4% +$6.68K 0.07% 172
2016
Q3 		$1.88M Buy
29,055
+197
+0.7% +$13.1K 0.07% 152
2016
Q2 		$1.82M Buy
28,858
+7,065
+32% +$416K 0.07% 134
2016
Q1 		$1.26M Buy
+21,793
New +$1.23M 0.05% 131

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Avalon Investment & Advisory's RMD Position: Q1 2019 in Review

Avalon Investment & Advisory sold out of ResMed (RMD) in Q1 2019, closing a stake of 24,918 shares — an estimated $2.84M sold.

Avalon Investment & Advisory first reported a position in RMD in Q1 2016 and held it in 12 quarters. The position peaked at $2.84M in Q4 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

  • Avalon Investment & Advisory reported no remaining ResMed position as of Q1 2019 after selling out during the quarter.
  • Avalon Investment & Advisory sold 24,918 ResMed shares in Q1 2019, an estimated $2.84M.
  • Avalon Investment & Advisory first reported a position in ResMed in Q1 2016 and held it in 12 quarters.
  • Avalon Investment & Advisory's ResMed position peaked at $2.84M in Q4 2018.
  • 477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on Avalon Investment & Advisory's 13F filing for Q1 2019, filed 24 Apr 2019.